Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05870488 · ClinicalTrials.gov registry record · Phase 4
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction
A Phase 4 study of Sacroiliac Joint Dysfunction and Sacroiliac; Fusion, sponsored by SI-BONE.
- Active
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
- 14
- Study locations
NCT05870488: Active Phase 4 study of Sacroiliac Joint Dysfunction and Sacroiliac; Fusion, sponsored by SI-BONE.
NCT05870488 is a Phase 4 study of Sacroiliac Joint Dysfunction and Sacroiliac; Fusion that is active but no longer recruiting, run by SI-BONE. The registered enrollment target is 110 participants, below the 177-participant average among 3 other Sacroiliac Joint Dysfunction trials with a reported enrollment target (38% lower). The trial reports 14 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05870488, a Phase 4 study of Sacroiliac Joint Dysfunction and Sacroiliac; Fusion, is active but no longer recruiting, sponsored by SI-BONE.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
- 14
- Study locations
Study Summary
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction (STACI) is a prospective, multicenter, study of SIJ fusion using the iFuse TORQ implant system.
Primary Outcome
Change in SI joint pain measured by NRS (0- no pain to 10- worst pain imaginable)
Conditions Studied
Interventions
- DEVICE Use of iFuse TORQ
Study Locations (14)
California
- Napa Valley Orthopaedics - Napa
- Source Healthcare - Santa Monica
Kansas
- Ascentist Healthcare - Leawood
- Crimson Pain Management - Overland Park
Indiana
- Comprehensive Pain and Spine Specialists - Shelbyville
Kentucky
- University of Kentucky - Lexington
Maryland
- Clearway Pain - Annapolis
Missouri
- St Louis Pain Consultants - Chesterfield
Nevada
- Nevada Advanced Pain - Reno
Oklahoma
- Clinical Investigations - Edmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2023-05-23 |
| Est. Completion | 2027-11 |
| Phase | Phase 4 |
What the registry record for NCT05870488 still lists
NCT05870488 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 177-participant average among 3 other Sacroiliac Joint Dysfunction trials with a reported enrollment target (38% lower).
The record links to 4 conditions, with Sacroiliac Joint Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Use of iFuse TORQ is the first listed.
NCT05870488 lists 14 locations in 12 states (California, Kansas, Indiana).
Frequently Asked Questions
What is clinical trial NCT05870488 about?
NCT05870488 is a clinical study titled "iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction". iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction (STACI) is a prospective, multicenter, study of SIJ fusion using the iFuse TORQ implant system.
What is the current status of trial NCT05870488?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2023-05-23. Estimated completion is 2027-11.
What conditions does trial NCT05870488 study?
This clinical trial studies the following conditions: Sacroiliac Joint Dysfunction, Sacroiliac; Fusion, Sacroiliac Joint Pain, Sacroiliac Disorder.
What interventions are being tested in trial NCT05870488?
The interventions under investigation include: Use of iFuse TORQ (DEVICE).
Who is sponsoring clinical trial NCT05870488?
This trial is sponsored by SI-BONE, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05870488 being conducted?
This trial has 14 study locations across California, Indiana, Kansas, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sacroiliac Joint Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI